Surging demand for Korean pharma in 2023 ahead of CPHI Korea
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Marks the World Head & Neck Cancer Day at the OCTF Conference
Subscribe To Our Newsletter & Stay Updated